Filing Flows › Comparisons › URGN vs AUPH
UroGen Pharma vs Aurinia Pharmaceuticals: URGN and AUPH compared
UroGen Pharma is the larger company: $89.0M of revenue in its latest quarter (Q3 2026) against $83.7M for Aurinia Pharmaceuticals (Q3 2026). UroGen Pharma is growing faster (+224% against +14% a year earlier). Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against 9.4%.
Where the money goes: URGN and AUPH
UroGen Pharma (URGN) · Q3 2026
UroGen Pharma, Q3 2026: revenue $89.0M (+224% year over year), operating margin 9.4%, net loss $1.5M, operating cash flow −$15.2M. The chart follows the revenue to costs, profit and cash.
Aurinia Pharmaceuticals (AUPH) · Q3 2026
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
| UroGen Pharma (URGN) | Aurinia Pharmaceuticals (AUPH) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $89.0M | $83.7M |
| Revenue growth, Y/Y | +224% | +14% |
| Operating margin | 9.4% | 42.3% |
| Net earnings | −$1.5M | $31.7M |
| Net margin | -1.6% | 37.9% |
| Operating cash flow | −$15.2M | $46.4M |
| Market value | — | $2.2B |
| P/E | — | 7.2× |
| Analysts’ mean target | — | $18.29 |
Where the revenue comes from
UroGen Pharma
- Zusduri: $68.0M (76%)
- Jelmyto: $21.0M (24%)
Aurinia Pharmaceuticals
- Net product sales: $79.4M (95%)
- License, collaboration and royalty revenue: $4.3M (5%)
Questions
Which is bigger, UroGen Pharma or Aurinia Pharmaceuticals?
UroGen Pharma is the larger company: $89.0M of revenue in its latest quarter (Q3 2026) against $83.7M for Aurinia Pharmaceuticals (Q3 2026).
Is UroGen Pharma or Aurinia Pharmaceuticals growing faster?
UroGen Pharma is growing faster (+224% against +14% a year earlier).
Which is more profitable, UroGen Pharma or Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against 9.4%.
More: UroGen Pharma earnings · how UroGen Pharma makes money · Aurinia Pharmaceuticals earnings · how Aurinia Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.